An interventional study of Stiff splint and No splint in Ulnar Nerve Transposition, sponsored by University of Chicago. Not yet recruiting at 5 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-22.
Sponsored by University of Chicago · Not applicable, Interventional, and Supportive care
The goal of this clinical trial is to learn whether patient recovery after ulnar nerve transposition (UNT) requires a splint. The main questions it aims to answer are:
Participants will be placed in a stiff splint (that limits elbow movement) or no splint (that allows for earlier elbow movement) after this surgery. Participants will report their recovery through surveys measuring physical function, pain, and sleep. Researchers will compare the results between the two types of splinting.
University of Chicago is the lead sponsor of 924 studies on the registry; 186 are open to participants now.
Of its 102 completed or terminated interventional studies of FDA-regulated products, 71 (70%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
- Additional procedures to be performed on ipsilateral or contralateral extremity
Participants receive a stiff splint that limits elbow movement
Procedure: Stiff splint
Participants receive a soft dressing that allows for movement.
Procedure: No splint
Participants receive a stiff splint that limits elbow movement
Participants receive a soft dressing that allows for movement.
Pittsburg Sleep Quality Index scores
A survey that measures self reported sleep measures from a score of 0 to 21 and a score over 5 indicates sleep difficulties and poor sleep quality.
Time frame: 2 weeks, 6 weeks, 3 months, 6 months, 1 year
Patient Reported Outcome Measures Information System (PROMIS)
The PROMIS physical function instrument measures self reported capability for daily physical activities and is scored on standardized norm-based-T-score where higher scores indicate greater physical capacity and functioning. The PROMIS upper extremity instrument measures physical capability related to the hand, wrist, arm and shoulder. Responses are scored on a standardized norm-based-T-score where higher scores indicate better function. The PROMIS Pain Interference instrument measures daily pain levels and how they interrupt daily function. Responses are scored on a standardized norm-based-T-score where higher scores indicate greater pain interference.
Time frame: 2 weeks, 6 weeks, 3 months, 6 months, 1 year
Average Patient-Reported Activity Level and Recovery Satisfaction
Measures how quickly the participant returns to normal function in daily life and activity in weeks. Each questionnaire has two scales that are asked at each time point up to one year post-surgery. One asks about current activity level compared to pre-surgery on a scale of 1-10 with 1 being significantly less active and 10 being significantly more active. The other asks about satisfaction with the recovery process on a scale of 1-10 with 1 being very dissatisfied and 10 being very satisfied.
Time frame: 2 weeks, 6 weeks, 3 months, 6 months, 1 year
Number of Patients with Post operative complications
Includes rates of complications (wound dehiscence, recurrent nerve instability, hematoma formation) and reoperation measured by yes or no question at each timepoint.
Time frame: 2 weeks, 6 weeks, 3 months, 6 months, 1 year
Change in Degrees of Elbow Range of Motion
Measures the change in elbow flexion after the procedure compared to the pre-operative baseline. The evaluation is performed during the standard clinical exam with a continuous scale of 0-145 degrees with a larger degree of flexion indicating better recovery and joint mobility.
Time frame: 2 weeks, 6 weeks, 3 months, 6 months, 1 year
Plan to share: No — There is not a plan to make IPD available.
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Feb 2028, 16 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.